Singapore, Feb. 10 -- Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations globally, announced the launch of Bridge-to-Biotech, a new initiative designed to support Japanese founders and entrepreneurs as they translate groundbreaking scientific discoveries into venture-ready biotechnology companies.

Bridge-to-Biotech reflects Saisei's commitment to company creation from the earliest stages of innovation, when clarity of direction and early execution play a meaningful role in shaping long-term outcomes. The program is designed initially for academic scientists and founders who are beginning the company formation process and seeking structured guidance and support as they sha...